Janux Therapeutics (JANX) EPS (Basic) (2020 - 2026)
Janux Therapeutics (JANX) posted quarterly EPS (Basic) of -$0.84 for Q1 2026, up 66.3% year-over-year from -$0.51 in Q1 2025, and down 63.62% quarter-over-quarter from -$0.52 in Q4 2025.
Janux Therapeutics (JANX) EPS (Basic) (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported EPS (Basic) for 7 consecutive years, with -$0.84 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 66.3% year-over-year to -$0.84; the TTM figure through Mar 2026 stood at -$5.56 (up 57.54% YoY), while the FY2025 annual figure was -$2.31, up 71.15% from the prior year.
- EPS (Basic) fell to -$0.84 in Q1 2026 per JANX's latest filing, from -$0.52 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.27 in Q4 2023 and bottomed at -$6.25 in Q3 2024.
- Historically, EPS (Basic) has averaged -$1.96 across 5 years, with a median of -$1.31 in 2022.
- Annual changes were most pronounced in 2024 — EPS (Basic) slumped 972.57% — and 2026, when it surged 66.3%.
- Janux Therapeutics' EPS (Basic) stood at -$0.4 in 2022, then surged by 32.49% to -$0.27 in 2023, then sank by 40.79% to -$0.38 in 2024, then plunged by 37.07% to -$0.52 in 2025, then slumped by 63.62% to -$0.84 in 2026.
- Business Quant data shows JANX's EPS (Basic) at -$0.84 in Q1 2026, -$0.52 in Q4 2025, and -$2.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Janux Therapeutics | 984.58 Mn | 984.58 Mn | - | -0.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.96 |
| Mar 31, 2026 | -0.84 |
| Dec 31, 2025 | -0.52 |
| Sep 30, 2025 | -2.11 |
| Jun 30, 2025 | -2.14 |
| Mar 31, 2025 | -2.50 |
| Dec 31, 2024 | -0.38 |
| Sep 30, 2024 | -6.25 |
| Jun 30, 2024 | -5.38 |
| Mar 31, 2024 | -5.47 |
| Dec 31, 2023 | -0.27 |
| Sep 30, 2023 | -0.58 |
| Jun 30, 2023 | -1.29 |
| Mar 31, 2023 | -1.31 |
| Dec 31, 2022 | -0.40 |
| Sep 30, 2022 | -1.31 |
| Jun 30, 2022 | -1.32 |
| Mar 31, 2022 | -1.17 |
| Dec 31, 2021 | -0.57 |
| Sep 30, 2021 | -2.03 |